|
Beyond GWAS: Leveraging Large-Scale Cancer Genomics Datasets for Germline Discovery
Chairperson: Elizabeth M. Gillanders, National Cancer Institute, Bethesda, MD
- Laura D. Buccini, National Cancer Institute, Bethesda, MD
- Matthew L. Freedman, Dana-Farber Cancer Institute, Boston, MA
- Simon A. Gayther, University of Southern California, Los Angeles, CA
- Elizabeth M. Gillanders
- Adam Kiezun, Broad Institute, Cambridge, MA
- Sharon E. Plon, Baylor College of Medicine, Houston, TX
- Kenna Shaw, National Cancer Institute, Bethesda, MD
The Cancer Genome Atlas (TCGA) – A Rapidly Expanding Community Resource: Status Review of Data Dissemination
Chairperson: Kenna Shaw, National Cancer Institute, Bethesda, MD
- Greg D. Eley, National Cancer Institute, Bethesda, MD
- Raju Kucherlapti, Harvard Medical School, Boston, MA
- Brad Ozenberger, National Human Genome Research Institute, Bethesda, MD
- Kenna Shaw
- Joshua M. Stuart, University of California, Santa Cruz, CA
Coordination of Collaborative Translational Cancer Research in Europe: Towards Evidence-Based Therapies and Care
Chairperson: Jan-Willem Van de Loo, European Commission, Brussels, Belgium
- Jurgen Becker, University of Graz, Graz, Austria
- Felix Beuschlein, University of Munich, Munich, Germany
- Charles Swanton, Cancer Research UK, London, United Kingdom
- Sabine Tejpar, University Hospital Leuven, Leuven, Belgium
- Jan-Willem Van de Loo
- Arend Von Stackelberg, Charité Medical University, Berlin, Germany
Funding Opportunities for Cancer Research at Multiple NIH Institutes and Centers with NIH Experts
Chairperson: Phuong Kim Pham, National Institute of Mental Health, Bethesda, MD
- Rajeev K. Agarwal, National Cancer Institute, Bethesda, MD
- Nancy C. Lohrey, National Cancer Institute, Bethesda, MD
- Pamela Anne Marino, National Institute of General Medical Sciences, Bethesda, MD
- Kimberly A. McAllister, National Institute of Environmental Health Sciences, Research Triangle Park, NC
- Phuong Kim Pham
- Lambratu Rahman-Sesay, Center for Scientific Review, Bethesda, MD
- Sundaresan Venkatachalam, National Institute of Dental and Craniofacial Research, Bethesda, MD
Funding Opportunities in Europe for Creative Minds from Anywhere in the World
- Mohamed Bentires-Alj, Sr., Friedrich Miescher Institute, Basel, Switzerland
- Cedric Blanpain, Université Libre de Bruxelles (ULB), Brussels, Belgium
- Hans Clevers, Hubrecht Institute, Utrecht, The Netherlands
- Michele De Palma, The Swiss Institute for Experimental Cancer Research (ISREC), Lausanne, Switzerland
- Sally A. Donaldson, European Research Council, Brussels, Belgium
- Klaus Pantel, University Medical Center Hamburg, Hamburg, Germany
- Eleni Zika, European Research Council, Brussels, Belgium
NCI Funding and Training Opportunities in Cancer Research
Co-Chairpersons: Jonathan S. Wiest, National Cancer Institute-Center for Cancer Training, Bethesda, MD; and Ming Lei, National Cancer Institute, Rockville, MD
- Ming Lei
- Jonathan S. Wiest
NCI SBIR and STTR: Advancing the Commercialization of New Cancer Innovations
Chairperson: Andrew J. Kurtz, National Cancer Institute, Bethesda, MD
- Gregory Evans, National Cancer Institute, Bethesda, MD
- James M. Olson, Fred Hutchinson Cancer Research Center, Seattle, WA
The NCI Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative: Using Large-Scale Genomics to Identify Novel Therapeutic Targets for Childhood Cancers
Co-Chairpersons: Malcolm A. Smith, National Cancer Institute, Bethesda, MD; and Jaime M. Guidry Auvil, National Cancer Institute, Bethesda, MD
- Edward F. Attiyeh, Children's Hospital of Philadelphia, Philadelphia, PA
- Tanja M. Davidsen, National Cancer Institute, Bethesda, MD
- Ching C. Lau, Texas Children's Cancer and Hematology Centers, Houston, TX
- Soheil Meshinchi, Fred Hutchinson Cancer Research Center, Seattle, WA
- Charles G. Mullighan, St. Jude Children's Research Hospital, Memphis, TN
- Elizabeth Perlman, Children's Memorial Research Center, Chicago, IL
NCI’s Early Detection Research Network: Progress and Outlook
Chairperson: Sudhir Srivastava, National Cancer Institute, Bethesda, MD
- Arul M. Chinnaiyan, University of Michigan, Ann Arbor, MI
- Sanford D. Markowitz, Case Western Reserve University, Cleveland, OH
- Pierre P. Massion, Vanderbilt University Medical Center, Nashville, TN
NCI’s Nanotechnology Characterization Laboratory: How to Evaluate Novel Materials for Cancer Therapy and Diagnosis
Chairperson: Piotr Grodzinski, National Cancer Institute, Bethesda, MD
- Neil A. Desai, Celgene Corp., Summit, NJ
- Jeff Hrkach, BIND Biosciences, Inc., Cambridge, MA
- Julia Y. Ljubimova, Cedars-Sinai Medical Center, Los Angeles, CA
- Scott E. McNeil, National Cancer Institute at Frederick, Frederick, MD
NCI’s Programs to Advance Cancer Research Utilizing Biospecimens
Chairperson: Benjamin Fombonne, National Cancer Institute, Bethesda, MD
- Anthony J. Dickherber, National Cancer Institute, Rockville, MD
- David Litwack, National Cancer Institute, Bethesda, MD
- Jimmie B. Vaught, National Cancer Institute, Bethesda, MD
NIH Grants Session: Changes in Review, Funding, and Funding Opportunities at the NCI
Chairperson: Suresh Mohla, National Cancer Institute-Division of Cancer Biology, Rockville, MD
- Suresh Mohla
- Angela Y. Ng, Center for Scientific Review, Bethesda, MD
Parlaying the K Award into Your First R01: How Did They Do It?
Co-Chairpersons: Ming Lei, National Cancer Institute, Rockville, MD; Sonia B. Jakowlew, National Cancer Institute, Bethesda, MD; and Nancy C. Lohrey, National Cancer Institute, Bethesda, MD
- Paige McDonald, National Cancer Institute, Rockville, MD
- John A. Milner, National Cancer Institute, Rockville, MD
- Suresh Mohla, National Cancer Institute-Division of Cancer Biology, Rockville, MD
- Christopher C. Quarles, Vanderbilt University, Nashville, TN
- Roy S. Wu, National Cancer Institute-Cancer Therapy Evaluation Program, Bethesda, MD
- Youli Zu, The Methodist Hospital, Houston, TX
Quantitative Imaging and Image-Guided Drug Delivery in Cancer
Chairperson: Keyvan Farahani, National Cancer Institute-Cancer Imaging Program, Bethesda, MD
- Zaver M. Bhujwalla, Johns Hopkins University School of Medicine, Baltimore, MD
- Keyvan Farahani
- Thomas J. Meade, Northwestern University, Evanston, IL
Technology Transfer and Intellectual Property: Financial and Career Opportunities for Researchers
Chairperson: Phuong Kim Pham, National Institute of Mental Health, Bethesda, MD
- Joseph Contrera, Johns Hopkins Technology Transfer, Baltimore, MD
- John De Kanel, Analytical Associates Inc., North Miami, FL
- Robert Iannone, Merck and Co. Inc., North Wales, PA
- Phuong Kim Pham
|